NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · IEX Real-Time Price · USD
3.140
+0.080 (2.61%)
At close: Apr 26, 2024, 3:59 PM
3.100
-0.040 (-1.27%)
After-hours: Apr 26, 2024, 5:59 PM EDT
NeuroBo Pharmaceuticals Market Cap
NeuroBo Pharmaceuticals has a market cap or net worth of $15.40 million as of April 26, 2024. Its market cap has decreased by -18.06% in one year.
Market Cap
15.40M
Enterprise Value
-6.83M
1-Year Change
-18.06%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since August 5, 2016, NeuroBo Pharmaceuticals's market cap has decreased from $84.50M to $15.40M, a decrease of -81.77%. That is a compound annual growth rate of -19.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 15.40M | 2.67% |
Apr 25, 2024 | 15.00M | -1.32% |
Apr 24, 2024 | 15.20M | 2.70% |
Apr 23, 2024 | 14.80M | -3.27% |
Apr 22, 2024 | 15.30M | -7.27% |
Apr 19, 2024 | 16.50M | -2.37% |
Apr 18, 2024 | 16.90M | -0.59% |
Apr 17, 2024 | 17.00M | 1.80% |
Apr 16, 2024 | 16.70M | -3.47% |
Apr 15, 2024 | 17.30M | -2.26% |
Apr 12, 2024 | 17.70M | 0.57% |
Apr 11, 2024 | 17.60M | 0.57% |
Apr 10, 2024 | 17.50M | 1.16% |
Apr 9, 2024 | 17.30M | -11.28% |
Apr 8, 2024 | 19.50M | 2.63% |
Apr 5, 2024 | 19.00M | -0.52% |
Apr 4, 2024 | 19.10M | - |
Apr 3, 2024 | 19.10M | -1.04% |
Apr 2, 2024 | 19.30M | -3.02% |
Apr 1, 2024 | 19.90M | -1.00% |
Mar 28, 2024 | 20.10M | -4.74% |
Mar 27, 2024 | 21.10M | 0.96% |
Mar 26, 2024 | 20.90M | -1.88% |
Mar 25, 2024 | 21.30M | -1.39% |
Mar 22, 2024 | 21.60M | -2.70% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cocrystal Pharma | 15.83M |
ABVC BioPharma | 15.63M |
Aytu BioPharma | 15.59M |
Psychemedics | 15.36M |
T2 Biosystems | 15.21M |
Mainz Biomed B.V. | 15.05M |
BioSig Technologies | 14.78M |
Pieris Pharmaceuticals | 14.75M |